Following an inspection earlier this year that yielded a Form 483, Indian generics juggernaut Alembic Pharmaceuticals has received a harsher reprimand from the U.S. FDA, though not for the sorts of ...
Alembic Pharmaceuticals share price rose in the opening trade on June 8 after the company signed a shareholders' agreement to invest in a newly incorporated Canadian entity, Canada Inc., aimed at ...
AI Quick Read Alembic Pharmaceuticals Ltd is expanding its branded speciality drugs portfolio in the US as part of a ‘twin engine play’ to boost growth in the market as generic pricing pressure ...
Vadodara: Alembic Pharmaceuticals has strengthened its US generics portfolio with a key regulatory approval, positioning itself to tap into a high-value diabetes treatment market. Alembic ...
Configuration settings can be accessed using cacholote.config.get() and modified using cacholote.config.set(**kwargs). It is possible to use cacholote.config.set ...
BEDMINSTER, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics is pleased to announce the U.S. availability of Pivya® (pivmecillinam) tablets, 185mg, an oral prescription antibiotic. Pivya ...
Drugmaker Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Travoprost Ophthalmic Solution ...
Led by Prysm Capital and Accenture with participation from Silver Lake Waterman, Liquid 2 Ventures, NextEquity, Friends & Family Capital, and WndrCo, this round positions Alembic among the top AI labs ...
Marketing startup Alembic announced that it has raised $145 million in its latest fundraising round. This most recent funding, the Series B round, has valued Alembic at $645 million. Growth equity ...
Alembic Technologies raises $145M and buys an Nvidia-powered supercomputer to accelerate ‘causal AI’
Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...
Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results